APUS

Business news, market intelligence, and global industry analysis.

The Latest

FDA Complete Response Letter puts Disc Medicine Inc.’s bitopertin timeline under pressure

What Humana Inc.’s MaxHealth acquisition signals for Medicare Advantage strategy

What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals

Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates

Apimeds–MindWave merger reshapes APUS into biotech and AI digital treasury hybrid backed by $100m PIPE

Apimeds and MindWave merge in a $100M PIPE-backed deal to create a biotech and AI digital treasury hybrid. Find out how APUS is reshaping its future today.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

December 1, 2025